5004 Multicenter phase I clinical trial of daily and weekly everolimus (RAD001) in combination with vinorelbine and trastuzumab in patients with HER-2-overexpressing metastatic breast cancer (MBC) with prior resistance to trastuzumab

详细信息    查看全文

• 作者：F. Cardoso ; L. Gianni ; G. Jerusalem ; A. Fasolo ; J. Bergh ; V. Dieras ; C. Manlius ; P. Mukhopadhyay ; C. Massacesi ; T. Sahmoud
• 刊名：European Journal of Cancer Supplements
• 出版年：2009
• 出版时间：September 2009
• 年：2009
• 卷：7
• 期：2
• 页码：261
• 全文大小：49 K

文摘